Sunday, April 29, 2012 11:43:01 AM
Just like your example below. From a 32 oz. Gatorade to a 16oz can of Monster, to an 8oz Can of Red Bull to a 2oz shot of 5 hour energy. The progression and acceptance of smaller equally if not more effective/healthy products have been accepted well in the market.
Now we have a Drop, that will enter the system in less than 90 seconds and provide an equal boost, electrolyte amount and nutrient formula as products that require larger consumption and dosing.
My belief is that it too will be received well.
As for the Pharma side, time will tell where this is going. We will get an update of some kind on the PR from December based on my response from IR.
Fuse Science, Inc. (www.fusescience.com), announced today the formal launch of its Hypoglycemic, Hyperglycemic, and Analgesic project platforms for the advancement of its OTC and pharmaceutical licensing efforts.
"We are extremely passionate about our work in this area," said Ed Maliski, Ph.D. & Lead scientist. "Our work is born out of diabetes sufferers on staff who are committed to advancing these platforms with sense of urgency. We have produced significant results with our OFD work and feel very confident at this stage with our ability to advance these project platforms."
One reason the "patent pending technology" is intriguing to me is that it could be a dosage control mechanism that would allow a sufficient, but precise amount of medication to be delivered, while still allowing for the digestive system to be bypassed (a device that works somewhere between a standard dropper and a teaspoon of liquid ibuprofen).
I believe you are SPOT ON here. Like Scooter said, Durshlag kept 1 patent.... License, the device and ...... well you know results the that would provide.
